Results 81 to 90 of about 6,464 (211)

Experience of using anidulafungin for treatment of invasive candidosis in patients after liver transplantation

Трансплантология (Москва), 2016
This article is an example of a successful treatment invasive fungal infections and bacterial infections caused by multidrug-resistant pathogen after liver ...
M. Sh. Khubutiya, N. K. Kuznetsova, S. V. Zhuravel, T. V. Chernenkaya, M. S. Novruzbekov, A. I. Bazhenov, I. I. Goncharova   +6 more
doaj  

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species

Journal of Fungi, 2020
Rezafungin is a next-generation echinocandin that has favorable pharmacokinetic properties. We compared the occurrence of paradoxical growth (PG) and trailing effect (TE) characteristics to echinocadins with rezafungin, caspofungin, micafungin and ...
Zoltán Tóth, Lajos Forgács, Tamás Kardos, Renátó Kovács, Jeffrey B. Locke, Gábor Kardos, Fruzsina Nagy, Andrew M. Borman, Awid Adnan, László Majoros   +9 more
doaj   +1 more source

Comparison of DermaGenius and In‐House qPCR Methods for Detection of Recalcitrant Dermatophyte Infections: A Practical Approach for Dermatologists and Mycologists

Mycoses, Volume 69, Issue 6, June 2026.
ABSTRACT Background Chronic and recalcitrant dermatophytosis has become increasingly problematic in dermatology practice, largely due to emerging antifungal resistance, affecting not only terbinafine but also azoles. Among the causative agents, Trichophyton indotineae has emerged as a key pathogen associated with treatment failure, extensive disease ...
Murat Durdu, Engin Kaplan, Oğuzhan Bingöl, Nevzat Ünal, Mehmet Emin Demircili, Bram Spruijtenburg, Carolina Melchior do Prado, Eelco F. J. Meijer, Macit Ilkit   +8 more
wiley   +1 more source

Micafungin versus anidulafungin in critically ill patients with invasive candidiasis: A retrospective study [PDF]

, 2016
_Background:_ In critically ill patients the incidence of invasive fungal infections caused by Candida spp. has increased remarkably. Echinocandins are recommended as initial treatment for invasive fungal infections. The safety and efficacy of micafungin
Geest, Patrick, Groeneveld, A.B.J. (Johan), Patrick J. van der Geest, Ladage, S.E. (Sophie E.), Ladage, Sophie, Geest, P.J. (Patrick) van der, Hunfeld, Nicole, Groeneveld, Johan, Sophie E. Ladage, A. B. Johan Groeneveld, Hunfeld, N.G.M. (Nicole), Nicole G. M. Hunfeld   +11 more
core   +1 more source

Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome

BMC Infectious Diseases, 2011
Background Candida albicans is the most common cause of candidemia and other forms of invasive candidiasis. Systemic infections due to C. albicans exhibit good susceptibility to fluconazole and echinocandins.
Reisman Arlene L, Schlamm Haran T, Kett Daniel H, Pappas Peter G, Rotstein Coleman, Shorr Andrew F, Reboli Annette C, Biswas Pinaki, Walsh Thomas J   +8 more
doaj   +1 more source

Repositioning 2‐Mercaptobenzothiazole and Sulfonamides as Antifungals Against Multidrug‐Resistant Candida albicans: In Vitro and In Silico Insights

ChemistrySelect, Volume 11, Issue 19, 20 May 2026.
This study highlights the antifungal potential of 2‐mercaptobenzothiazole (MBT) and sulfonamides against multidrug‐resistant Candida albicans. In vitro assays and molecular docking with lanosterol 14α‐demethylase (L14αDM) reveal favorable activity and binding, supporting their repositioning as promising antifungal candidates. ABSTRACT Fungal infections
Bruno A. de Oliveira, Ari Sérgio de Oliveira Lemos, Gabrielle Silva de Campos Lazzarini, Natasha Silva Mayrink, Elaine Soares Coimbra, Adilson D. da Silva, Rodrigo Luiz Fabri   +6 more
wiley   +1 more source

Pharmakokinetik von Anidulafungin während kontinuierlicher Hämofiltration [PDF]

, 2010
Anidulafungin, ein Echinocandin-Antimykotikum, welches zur neuesten Substanzklasse von Antimykotika gehört, weist ein breites Wirkspektrum gegen Candida-Infektionen und Aspergillosen auf. Der Arzneistoff wird bei schweren systemischen Mykosen eingesetzt.
Stelzer, Christoph
core  

Anidulafungin-a new therapeutic option for Candida infections in liver transplantation. [PDF]

, 2012
INTRODUCTION: In the last years, the incidence of Candida infections in liver transplant recipients has increased with still higher morbidity and mortality. Anidulafungin, a new echinocandin that does not interfere with cytochrome p450, shows no need for
Bianco, Giuseppe, Sganga, Gabriele, Nure, Erida, Pepe, Gilda, Lirosi, Maria Carmen, Frongillo, Francesco, Agnes, Salvatore, Grossi, Ugo   +7 more
core   +3 more sources

In Vitro Activitiy of Rezafungin in Comparison with Anidulafungin and Caspofungin against Invasive Fungal Isolates (2017 to 2022) in China

Journal of Fungi
The efficacy of different echinocandins is assessed by evaluating the in vitro activity of a novel antifungal, rezafungin, against invasive fungal isolates in comparison with anidulafungin and caspofungin.
Simin Yang, Feifei Wan, Min Zhang, Huiping Lin, Liang Hu, Ziyi Zhou, Dongjiang Wang, Aiping Zhou, Lijun Ni, Jian Guo, Wenjuan Wu   +10 more
doaj   +1 more source

Susceptibility of the Candida haemulonii Complex to Echinocandins: Focus on Both Planktonic and Biofilm Life Styles and a Literature Review

Journal of Fungi, 2020
Candida haemulonii complex (C. haemulonii, C. duobushaemulonii and C. haemulonii var. vulnera) is well-known for its resistance profile to different available antifungal drugs.
Lívia S. Ramos, Laura N. Silva, Marta H. Branquinha, André L. S. Santos   +3 more
doaj   +1 more source